2020 Life Sciences Sector Report from CLSA Shows Strong Growth in Jobs, Investments and Therapeutic Pipeline in California
Patrick Henning to lead CLSA’s Federal, State and Local Government Relations, Communications, Policy and Alliance Development Efforts on behalf of California’s life sciences sector
Federal Appropriations Update – Continuing Resolution Likely Through Dec. 11
On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.
Governor Newsom Signs Bill to Protect Biomedical Research
On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
CLSA Statement on “Lowering Drug Prices by Putting America First” Executive Order issued 9/13/20
On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.
CA Supreme Court Strikes Down Hearing on 2018 Ballot Tax Measure
California Life Sciences Association (CLSA) welcomes the Los Angeles World Airports (LAWA) vision to begin the RFQ/RFP process for the development of a biomedical complex on the LAWA northside area site. This concept will greatly bolster California’s ability to keep up with the needs of the sector and further provide economic development opportunities for innovative life science companies.
CLSA is pleased to welcome Catalent Biologics into the life sciences community as our newest Strategic Partner
Patrick Henning to lead CLSA’s Federal, State and Local Government Relations, Communications, Policy and Alliance Development Efforts on behalf of California’s life sciences sector
What’s on The Ballot? Here’s A Look at California’s 2020 Propositions
On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
The California legislature was rocked by a new round of positive COVID tests last week
On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
CLSA Joins PFID Letters on AMR
On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.
White House Issues Executive Orders Impacting the Life Sciences
On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.